Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6829355 | Schizophrenia Research | 2007 | 5 Pages |
Abstract
Atypical antipsychotics may offer an advantage in reducing substance use among schizophrenia patients. For patients to benefit from atypical antipsychotics, treatment should focus on enhancing compliance and integrating substance use treatment.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jeffrey Swanson, Richard A. Van Dorn, Marvin S. Swartz,